Post Stroke Epilepsy Clinical Trial
Official title:
Clinical Multi-center Study of Mitochondrial Brain Protective Agent Idebenone in the Prevention of Post-stroke Epilepsy
According to the random number table, all patients were divided into short-term treatment group, long-term treatment group and non-intervention stroke control group according to the proportion of (1:1:1) epilepsy disease modifier idebenone. Patients in the short-term treatment group will take idebenone for a total course of 14 days (acute period) after stroke, and patients in the long-term treatment group will take idebenone for a total course of 3 months after stroke.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05864547 -
Predisposing Factors for Post-stroke Epilepsy
|
||
| Enrolling by invitation |
NCT06108102 -
International Post-Stroke Epilepsy Research Repository
|
||
| Recruiting |
NCT03848273 -
Post Stroke Epileptic Seizures Risk Forecast
|